Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Related Articles
Heart Failure with Preserved Ejection Fraction | NEJM
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes…
Pace4Life: A sustainable mission to save lives globally – touchCARDIOLOGY
Join us in this episode as Trudie Lobban, Founder and Trustee of Arrhythmia Alliance, discusses the remarkable work of Pace4Life. This innovative charity
Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis
The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment decisions.
Action Alerts – American College of Cardiology
With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However,…
60 Years After JFK’s Death It Is More and More Apparent that Kennedy Was a Victim of a Palace Coup—Spearheaded by Vice-President Johnson – CovertAction Magazine
The peaceful succession of presidents is sacrosanct in American democracy and marks the United States as an “exceptional nation” which does not experience the same…
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care
Many cancer decedents in the United States had an implantable cardioverter defibrillator (ICD), and those with ICDs received more aggressive care at the end of…
Exploring the ‘new era’ of HFpEF treatment: More options exist, but challenges remain
Clyde Yancy, MD, spoke with Cardiovascular Business about how the treatment of heart failure with preserved ejection fraction (HFpEF) has evolved in recent years.
Avoiding the Things That Can Go Bump in the Night After Cardiac Surgery
In this month’s issue of The Annals, Wisniewski and associates1 have reported on the results of an observational study investigating the association between the timing…
Events | Verve Therapeutics
The Investor Relations website contains information about Verve Therapeutics’s business for stockholders, potential investors, and financial analysts.
